» Articles » PMID: 38264719

AlphaML: A Clear, Legible, Explainable, Transparent, and Elucidative Binary Classification Platform for Tabular Data

Overview
Journal Patterns (N Y)
Date 2024 Jan 24
PMID 38264719
Authors
Affiliations
Soon will be listed here.
Abstract

Leveraging the potential of machine learning and recognizing the broad applications of binary classification, it becomes essential to develop platforms that are not only powerful but also transparent, interpretable, and user friendly. We introduce alphaML, a user-friendly platform that provides clear, legible, explainable, transparent, and elucidative (CLETE) binary classification models with comprehensive customization options. AlphaML offers feature selection, hyperparameter search, sampling, and normalization methods, along with 15 machine learning algorithms with global and local interpretation. We have integrated a custom metric for hyperparameter search that considers both training and validation scores, safeguarding against under- or overfitting. Additionally, we employ the NegLog2RMSL scoring method, which uses both training and test scores for a thorough model evaluation. The platform has been tested using datasets from multiple domains and offers a graphical interface, removing the need for programming expertise. Consequently, alphaML exhibits versatility, demonstrating promising applicability across a broad spectrum of tabular data configurations.

Citing Articles

XeroGraph: enhancing data integrity in the presence of missing values with statistical and predictive analysis.

Mousafi Alasal L, Hammarlund E, Pienta K, Ronnstrand L, Kazi J Bioinform Adv. 2025; 5(1):vbaf035.

PMID: 40061871 PMC: 11889451. DOI: 10.1093/bioadv/vbaf035.


Xputer: bridging data gaps with NMF, XGBoost, and a streamlined GUI experience.

Younus S, Ronnstrand L, Kazi J Front Artif Intell. 2024; 7:1345179.

PMID: 38720912 PMC: 11076752. DOI: 10.3389/frai.2024.1345179.


AlphaML: A clear, legible, explainable, transparent, and elucidative binary classification platform for tabular data.

Nasimian A, Younus S, Tatli O, Hammarlund E, Pienta K, Ronnstrand L Patterns (N Y). 2024; 5(1):100897.

PMID: 38264719 PMC: 10801203. DOI: 10.1016/j.patter.2023.100897.


PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.

Shah K, Nasimian A, Ahmed M, Al Ashiri L, Denison L, Sime W Blood Cancer J. 2023; 13(1):139.

PMID: 37679323 PMC: 10484999. DOI: 10.1038/s41408-023-00914-7.

References
1.
Bottomly D, Long N, Schultz A, Kurtz S, Tognon C, Johnson K . Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022; 40(8):850-864.e9. PMC: 9378589. DOI: 10.1016/j.ccell.2022.07.002. View

2.
Nasimian A, Ahmed M, Hedenfalk I, Kazi J . A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. Comput Struct Biotechnol J. 2023; 21:956-964. PMC: 9876747. DOI: 10.1016/j.csbj.2023.01.020. View

3.
Lundberg S, Erion G, Chen H, DeGrave A, Prutkin J, Nair B . From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020; 2(1):56-67. PMC: 7326367. DOI: 10.1038/s42256-019-0138-9. View

4.
Shah K, Nasimian A, Ahmed M, Al Ashiri L, Denison L, Sime W . PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia. Blood Cancer J. 2023; 13(1):139. PMC: 10484999. DOI: 10.1038/s41408-023-00914-7. View

5.
Shah K, Al Ashiri L, Nasimian A, Ahmed M, Kazi J . Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling. Int J Mol Sci. 2023; 24(5). PMC: 10003524. DOI: 10.3390/ijms24055004. View